We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.54%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$124M |
| 3 |
Broadridge
BR
|
+$105M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$101M |
| 5 |
Motorola Solutions
MSI
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$332M |
| 2 |
NVIDIA
NVDA
|
+$268M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$190M |
| 4 |
TSMC
TSM
|
+$149M |
| 5 |
Cisco
CSCO
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.97% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Dutch Bros
BROS
$9.09B
| $470K | ﹤0.01% |
14,488
-8,800
| -38% | -$331K |
|
1302
Lennox International
LII
$15.6B
| $468K | ﹤0.01% |
2,104
| – | – |
|
1303
Rapid Micro Biosystems
RPID
$104M
| $467K | ﹤0.01% |
133,814
| – | – |
|
1304
Arrow Electronics
ARW
$11.5B
| $466K | ﹤0.01% |
5,004
-100
| -2% | -$10.9K |
|
1305
Rocket Pharmaceuticals
RCKT
$382M
| $465K | ﹤0.01% |
33,152
-33,031
| -50% | -$515K |
|
1306
Resources Connection
RGP
$155M
| $463K | ﹤0.01% |
25,900
+11,500
| +80% | +$231K |
|
|
VERV
1307
DELISTED
Verve Therapeutics
VERV
| $463K | ﹤0.01% |
+13,542
| New | +$432K |
|
1308
Futu Holdings
FUTU
$15.7B
| $462K | ﹤0.01% |
12,684
-316
| -2% | -$13.8K |
|
1309
Orchestra BioMed
OBIO
$253M
| $459K | ﹤0.01% |
46,339
| – | – |
|
|
CNR
1310
Core Natural Resources Inc
CNR
$4.16B
| $457K | ﹤0.01% |
7,000
+1,100
| +19% | +$69.6K |
|
1311
Nkarta
NKTX
$160M
| $452K | ﹤0.01% |
35,784
| – | – |
|
1312
Relmada Therapeutics
RLMD
$561M
| $452K | ﹤0.01% |
12,500
+500
| +4% | +$13.9K |
|
1313
Par Pacific Holdings
PARR
$3.74B
| $448K | ﹤0.01% |
+28,200
| New | +$479K |
|
1314
Pennant Group
PNTG
$1.36B
| $448K | ﹤0.01% |
41,636
| – | – |
|
|
BLSA
1315
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $443K | ﹤0.01% |
44,047
| – | – |
|
|
VTLE
1316
DELISTED
Vital Energy
VTLE
| $442K | ﹤0.01% |
+7,000
| New | +$498K |
|
1317
Erie Indemnity
ERIE
$12.9B
| $441K | ﹤0.01% |
2,005
+110
| +6% | +$23.2K |
|
|
OBE
1318
Obsidian Energy
OBE
$614M
| $439K | ﹤0.01% |
61,000
-7,663
| -11% | -$62.2K |
|
1319
Alpha and Omega Semiconductor
AOSL
$992M
| $436K | ﹤0.01% |
+13,600
| New | +$503K |
|
1320
Dynatrace
DT
$14.8B
| $435K | ﹤0.01% |
12,579
-400
| -3% | -$15.5K |
|
1321
Vale
VALE
$63.2B
| $433K | ﹤0.01% |
34,188
-955
| -3% | -$12.6K |
|
1322
Kodiak Sciences
KOD
$2.7B
| $425K | ﹤0.01% |
55,986
+100
| +0.2% | +$972 |
|
|
SWTX
1323
DELISTED
SpringWorks Therapeutics
SWTX
| $424K | ﹤0.01% |
15,616
| – | – |
|
1324
HEICO Corp
HEI
$51.5B
| $417K | ﹤0.01% |
2,904
+70
| +2% | +$10.5K |
|
1325
C4 Therapeutics
CCCC
$401M
| $414K | ﹤0.01% |
48,453
-6,700
| -12% | -$69.6K |
|
Similar funds
VAM
TD Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, TD Asset Management held 1,534 positions worth $79.9B, down 7.5% from $86.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TD Asset Management's Q3 2022 filing shows 77 new, 494 increased, 709 reduced and 60 closed positions. Its largest new stake was Eagle Materials: 154,517 shares worth $16.4M. The largest sale was Atlassian, an estimated $332M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q3 2022 buy was Eagle Materials: 154,517 shares worth $16.4M.
- TD Asset Management added most to Thermo Fisher Scientific in Q3 2022, an estimated $128M increase.
- TD Asset Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $268M.
- TD Asset Management fully exited Atlassian in Q3 2022, selling an estimated $332M.
- TD Asset Management's ten largest holdings make up 29% of its $79.9B portfolio in Q3 2022.
- TD Asset Management opened 77 new positions and closed 60 in Q3 2022.
- TD Asset Management's portfolio value fell 7.5% quarter-over-quarter to $79.9B.
Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.